Gartner, Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -25

Gartner Gears Up to Report Q1 Earnings: What's in the Offing?

AI-generated analysis

πŸ“… Gartner Inc. is scheduled to report its first-quarter 2026 earnings results before market open on May 5.

πŸ“‰ The Zacks Consensus Estimate for Gartner's top-line revenue is pegged at $1.5 billion, indicating a marginal dip from the prior-year quarter.

πŸ’° Revenue estimates suggest slight growth across specific segments: Insights (+1.9%), Conferences (+7.4%), and Consulting (-3.8% decline).

πŸ“Š The consensus earnings per share (EPS) estimate for Gartner is set at $2.99, implying slight growth from the year-ago quarter.

⚠️ Zacks model currently assigns Gartner a Rank of 4 (Sell) with an Earnings ESP of 0.00%, reducing the odds of an earnings beat.

πŸ“ˆ The article shifts focus to other potential performers, highlighting Coherent Corp. (COHR) which is expected to report on May 6.

πŸ’‘ Coherent Corp. has a Zacks Rank of 2 (Buy), an Earnings ESP of +3.08%, and consensus revenue growth of 18.8% year-over-year.

πŸ“‰ Coherent Corp. has a history of missing estimates in the trailing four quarters with an average surprise of -7.7%.

πŸ’Š BridgeBio Pharma (BBIO) is set to report on May 7 with estimated revenue growth of 54.2% and reduced losses.

πŸ§ͺ BridgeBio Pharma holds a Zacks Rank of 3 (Hold), an Earnings ESP of +1.28%, and a history of mixed earnings surprises.

πŸš€ The article concludes by promoting a separate research list of five stocks with high probabilities of doubling in value.

πŸ›°οΈ One top pick from that list is a little-known satellite-based communications firm projected to break out in revenue in 2025.

πŸ“ˆ Historical context notes another company, Hims & Hers Health, previously rose +209% after being named in similar lists.

⚠️ Disclosures state the article contains syndicated content from Zacks Investment Research which has not been reviewed by the host site.

πŸ’° The source mentions potential compensation for the placement of this syndicated content on the publishing platform.

Bullish Signals
  • Gartner Inc. has an impressive earnings surprise history, surpassing the Zacks Consensus Estimate with an average surprise of 10.3% over the four trailing quarters.
  • The Insights segment's gross contribution is projected to grow 1.9% from the year-ago quarter, reaching $1 billion.
  • Conferences revenues are expected to rise by 2.7% to $75 million, while gross contribution for this segment shows a strong 7.4% year-over-year increase to $29 million.
  • Earnings per share consensus estimates suggest slight growth from the year-ago quarter at $2.99 per share.
  • Gartner holds a Zacks Rank of 4 (Sell) with an Earnings ESP of 0.00%, but historical data indicates strong potential to exceed expectations.
Risk Factors
  • Gartner's Zacks Rank is currently rated 4 (Sell), indicating analysts view it with significant caution compared to the Strong Buy or Buy ratings assigned to other featured stocks.
  • The consensus estimate for Gartner's top line revenue implies a marginal dip from the year-ago quarter, signaling potential top-line weakness upon earnings release.
  • Gartner is projected to see a 2.9% year-over-year decline in Insights segment revenues and a marginal dip in Consulting revenues according to consensus estimates.
  • Consulting gross contribution is forecasted at $51 million, implying a 3.8% decline from the year-ago quarter's actual.
  • Gartner's Earnings ESP stands at 0.00%, meaning analysts do not currently expect an earnings beat for the upcoming quarter.
  • Unlike other stocks highlighted in the article that have positive Earnings ESP percentages, Gartner shows no expected upside surprise in earnings.
Full Analysis
Gartner Inc. (IT) is set to report its first-quarter 2026 earnings on May 5 before the market opens, with analysts expecting a slight decline in top-line revenue compared to the same period last year. The Zacks Consensus Estimate for total revenue is pinned at $1.5 billion, down from the previous quarter's actuals, while the Insights segment is projected to see a 2.9% year-over-year dip to $1.3 billion and the Consulting segment expects a marginal decline. However, gross contribution is anticipated to grow modestly by 1.9% to $1 billion in the Insights segment, with conferences showing stronger growth at 7.4% increase to $29 million. Earnings per share are forecasted to rise slightly to $2.99, reflecting overall growth despite top-line pressure. The article notes that Gartner's recent earnings history has been strong, with a positive surprise average of 10.3% over the last four trailing quarters. However, current models do not predict an earnings beat for this upcoming report, as the company currently holds a Zacks Rank of 4 (Sell) and an Earnings ESP of 0.00%. The analysis suggests that while positive historical earnings surprises and certain Zacks Rank upgrades typically increase the likelihood of beating estimates, Gartner's current metrics do not align with those favorable predictors. Beyond the primary subject, the article briefly mentions other stocks such as Coherent Corp. (COHR) and BridgeBio Pharma (BBIO), providing their respective revenue and earnings forecasts for the same period in Q1 2026, along with their Zacks Ranks and Earnings ESPs. Additionally, it includes promotional content about a research chief's top stock pick aimed at potentially doubling investors' money, highlighting space sector growth and referencing Hims & Hers Health as a previous example of significant gains. The piece concludes by directing readers to external resources for analyst roundups, upgrades/downgrades, and daily investor briefings.